articleTop 10% cited

Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA)

European Journal of Endocrinology · 2004 · Vol. 151(4) · pp. 439–446

Antonio Mestrón(Hospital de Nens de Barcelona)Susan M. Webb✉(Universitat Autònoma de Barcelona)R. Astorga(Hospital Universitario Virgen del Rocío)Pedro J. Benito(Hospital Universitario Reina Sofía)Martin Catala(Hospital Clínico Universitario de Valencia)Sonia Gaztambide(Hospital de Cruces)JM Gómez(Universitat de Barcelona)Irene Halperín(Universitat de Barcelona)T Lucas-Morante(Universidad Autónoma de Madrid)B. Moreno(Hospital General Universitario Gregorio Marañón)Gabriel Obiols(Vall d'Hebron Hospital Universitari)P. de Pablos(Hospital Universitario de Gran Canaria Doctor Negrín)C. Páramo(Complexo Hospitalario Universitario A Coruña)Antonio Picó(Universitat de Miguel Hernández d'Elx)E. Torres(Instituto de Investigación Biosanitaria de Granada)C Varela(Hospital Universitario Ramón y Cajal)JA Vazquez(Hospital de Cruces)Javier ZamoraM. Albareda(Hospital de Nens de Barcelona)Montserrat Gilabert(Novartis (Spain))

View via DOI Publisher page

Abstract

This acromegaly registry offers a realistic overview of the epidemiological characteristics, treatment outcome and morbidity of acromegaly in Spain. As active disease and treatment with radiotherapy are associated with an increase in mortality, efforts to control the disease early are desirable.

Pituitary Gland Disorders and Treatments Growth Hormone and Insulin-like Growth Factors Adrenal and Paraganglionic TumorsAcromegalyMedicineEpidemiologyDiabetes mellitusHypopituitarismPegvisomantInternal medicineCohortRadiation therapyPediatrics